467 related articles for article (PubMed ID: 25339767)
21. Two Families of Env Antibodies Efficiently Engage Fc-Gamma Receptors and Eliminate HIV-1-Infected Cells.
Anand SP; Prévost J; Baril S; Richard J; Medjahed H; Chapleau JP; Tolbert WD; Kirk S; Smith AB; Wines BD; Kent SJ; Hogarth PM; Parsons MS; Pazgier M; Finzi A
J Virol; 2019 Feb; 93(3):. PubMed ID: 30429344
[TBL] [Abstract][Full Text] [Related]
22. Cross-Linking of a CD4-Mimetic Miniprotein with HIV-1 Env gp140 Alters Kinetics and Specificities of Antibody Responses against HIV-1 Env in Macaques.
Shen X; Bogers WM; Yates NL; Ferrari G; Dey AK; Williams WT; Jaeger FH; Wiehe K; Sawant S; Alam SM; LaBranche CC; Montefiori DC; Martin L; Srivastava I; Heeney J; Barnett SW; Tomaras GD
J Virol; 2017 Oct; 91(19):. PubMed ID: 28490585
[TBL] [Abstract][Full Text] [Related]
23. Common antibody dependent cell mediated cytotoxicity (ADCC) antibody epitopes of HIV-1 CRF01_AE Env and Gag in early HIV-1 infected individuals.
Sangjan S; Ampol S; Tabprasit S; Horthongkham N; Chuenchitra T; Ekpo P; Kantakamalakul W
Asian Pac J Allergy Immunol; 2019 Mar; 37(1):43-50. PubMed ID: 29602284
[TBL] [Abstract][Full Text] [Related]
24. Recognition Patterns of the C1/C2 Epitopes Involved in Fc-Mediated Response in HIV-1 Natural Infection and the RV114 Vaccine Trial.
Tolbert WD; Van V; Sherburn R; Tuyishime M; Yan F; Nguyen DN; Stanfield-Oakley S; Easterhoff D; Bonsignori M; Haynes BF; Moody MA; Ray K; Ferrari G; Lewis GK; Pazgier M
mBio; 2020 Jun; 11(3):. PubMed ID: 32605979
[TBL] [Abstract][Full Text] [Related]
25. Predominant envelope variable loop 2-specific and gp120-specific antibody-dependent cellular cytotoxicity antibody responses in acutely SIV-infected African green monkeys.
Nguyen QN; Martinez DR; Himes JE; Whitney Edwards R; Han Q; Kumar A; Mangan R; Nicely NI; Xie G; Vandergrift N; Shen X; Pollara J; Permar SR
Retrovirology; 2018 Mar; 15(1):24. PubMed ID: 29523166
[TBL] [Abstract][Full Text] [Related]
26. Pharmacologic Inhibition of Nedd8 Activation Enzyme Exposes CD4-Induced Epitopes within Env on Cells Expressing HIV-1.
Tokarev A; Stoneham C; Lewinski MK; Mukim A; Deshmukh S; Vollbrecht T; Spina CA; Guatelli J
J Virol; 2015 Dec; 90(5):2486-502. PubMed ID: 26676780
[TBL] [Abstract][Full Text] [Related]
27. Antibody Recognition of CD4-Induced Open HIV-1 Env Trimers.
Yang Z; Dam KA; Gershoni JM; Zolla-Pazner S; Bjorkman PJ
J Virol; 2022 Dec; 96(24):e0108222. PubMed ID: 36448805
[TBL] [Abstract][Full Text] [Related]
28. A Trimeric HIV-1 Envelope gp120 Immunogen Induces Potent and Broad Anti-V1V2 Loop Antibodies against HIV-1 in Rabbits and Rhesus Macaques.
Jones AT; Chamcha V; Kesavardhana S; Shen X; Beaumont D; Das R; Wyatt LS; LaBranche CC; Stanfield-Oakley S; Ferrari G; Montefiori DC; Moss B; Tomaras GD; Varadarajan R; Amara RR
J Virol; 2018 Mar; 92(5):. PubMed ID: 29237847
[TBL] [Abstract][Full Text] [Related]
29. An Asymmetric Opening of HIV-1 Envelope Mediates Antibody-Dependent Cellular Cytotoxicity.
Alsahafi N; Bakouche N; Kazemi M; Richard J; Ding S; Bhattacharyya S; Das D; Anand SP; Prévost J; Tolbert WD; Lu H; Medjahed H; Gendron-Lepage G; Ortega Delgado GG; Kirk S; Melillo B; Mothes W; Sodroski J; Smith AB; Kaufmann DE; Wu X; Pazgier M; Rouiller I; Finzi A; Munro JB
Cell Host Microbe; 2019 Apr; 25(4):578-587.e5. PubMed ID: 30974085
[TBL] [Abstract][Full Text] [Related]
30. Piperidine CD4-Mimetic Compounds Expose Vulnerable Env Epitopes Sensitizing HIV-1-Infected Cells to ADCC.
Ding S; Tolbert WD; Zhu H; Lee D; Marchitto L; Higgins T; Zhao X; Nguyen D; Sherburn R; Richard J; Gendron-Lepage G; Medjahed H; Mohammadi M; Abrams C; Pazgier M; Smith AB; Finzi A
Viruses; 2023 May; 15(5):. PubMed ID: 37243271
[TBL] [Abstract][Full Text] [Related]
31. Evidence for a defect of antibody-dependent cellular cytotoxic (ADCC) effector function and anti-HIV gp120/41-specific ADCC-mediating antibody titres in HIV-infected individuals.
Ahmad A; Morisset R; Thomas R; Menezes J
J Acquir Immune Defic Syndr (1988); 1994 May; 7(5):428-37. PubMed ID: 7908983
[TBL] [Abstract][Full Text] [Related]
32. Envelope glycoproteins sampling states 2/3 are susceptible to ADCC by sera from HIV-1-infected individuals.
Prévost J; Richard J; Ding S; Pacheco B; Charlebois R; Hahn BH; Kaufmann DE; Finzi A
Virology; 2018 Feb; 515():38-45. PubMed ID: 29248757
[TBL] [Abstract][Full Text] [Related]
33. Vaccine-induced HIV-1 envelope gp120 constant region 1-specific antibodies expose a CD4-inducible epitope and block the interaction of HIV-1 gp140 with galactosylceramide.
Dennison SM; Anasti KM; Jaeger FH; Stewart SM; Pollara J; Liu P; Kunz EL; Zhang R; Vandergrift N; Permar S; Ferrari G; Tomaras GD; Bonsignori M; Michael NL; Kim JH; Kaewkungwal J; Nitayaphan S; Pitisuttithum P; Rerks-Ngarm S; Liao HX; Haynes BF; Alam SM
J Virol; 2014 Aug; 88(16):9406-17. PubMed ID: 24920809
[TBL] [Abstract][Full Text] [Related]
34. eCD4-Ig promotes ADCC activity of sera from HIV-1-infected patients.
Davis-Gardner ME; Gardner MR; Alfant B; Farzan M
PLoS Pathog; 2017 Dec; 13(12):e1006786. PubMed ID: 29253851
[TBL] [Abstract][Full Text] [Related]
35. Small CD4 mimetics sensitize HIV-1-infected macrophages to antibody-dependent cellular cytotoxicity.
Laumaea A; Marchitto L; Ding S; Beaudoin-Bussières G; Prévost J; Gasser R; Chatterjee D; Gendron-Lepage G; Medjahed H; Chen HC; Smith AB; Ding H; Kappes JC; Hahn BH; Kirchhoff F; Richard J; Duerr R; Finzi A
Cell Rep; 2023 Jan; 42(1):111983. PubMed ID: 36640355
[TBL] [Abstract][Full Text] [Related]
36. Epitope specificity of human immunodeficiency virus-1 antibody dependent cellular cytotoxicity [ADCC] responses.
Pollara J; Bonsignori M; Moody MA; Pazgier M; Haynes BF; Ferrari G
Curr HIV Res; 2013 Jul; 11(5):378-87. PubMed ID: 24191939
[TBL] [Abstract][Full Text] [Related]
37. A Highly Conserved Residue of the HIV-1 gp120 Inner Domain Is Important for Antibody-Dependent Cellular Cytotoxicity Responses Mediated by Anti-cluster A Antibodies.
Ding S; Veillette M; Coutu M; Prévost J; Scharf L; Bjorkman PJ; Ferrari G; Robinson JE; Stürzel C; Hahn BH; Sauter D; Kirchhoff F; Lewis GK; Pazgier M; Finzi A
J Virol; 2016 Feb; 90(4):2127-34. PubMed ID: 26637462
[TBL] [Abstract][Full Text] [Related]
38. Lack of ADCC Breadth of Human Nonneutralizing Anti-HIV-1 Antibodies.
Bruel T; Guivel-Benhassine F; Lorin V; Lortat-Jacob H; Baleux F; Bourdic K; Noël N; Lambotte O; Mouquet H; Schwartz O
J Virol; 2017 Apr; 91(8):. PubMed ID: 28122982
[TBL] [Abstract][Full Text] [Related]
39. A New Family of Small-Molecule CD4-Mimetic Compounds Contacts Highly Conserved Aspartic Acid 368 of HIV-1 gp120 and Mediates Antibody-Dependent Cellular Cytotoxicity.
Ding S; Grenier MC; Tolbert WD; Vézina D; Sherburn R; Richard J; Prévost J; Chapleau JP; Gendron-Lepage G; Medjahed H; Abrams C; Sodroski J; Pazgier M; Smith AB; Finzi A
J Virol; 2019 Dec; 93(24):. PubMed ID: 31554684
[TBL] [Abstract][Full Text] [Related]
40. HIV Nef and Vpu protect HIV-infected CD4+ T cells from antibody-mediated cell lysis through down-modulation of CD4 and BST2.
Pham TN; Lukhele S; Hajjar F; Routy JP; Cohen ÉA
Retrovirology; 2014 Feb; 11():15. PubMed ID: 24498878
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
